Aqr Capital Management LLC Heron Therapeutics, Inc. Transaction History
Aqr Capital Management LLC
- $75.6 Billion
- Q4 2024
A detailed history of Aqr Capital Management LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 214,957 shares of HRTX stock, worth $485,802. This represents 0.0% of its overall portfolio holdings.
Number of Shares
214,957
Previous 900,107
76.12%
Holding current value
$485,802
Previous $1.79 Million
81.69%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding HRTX
# of Institutions
172Shares Held
114MCall Options Held
2MPut Options Held
32.4K-
Rubric Capital Management LP New York, NY26.7MShares$60.4 Million0.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.5MShares$19.2 Million0.02% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$18.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.16MShares$18.4 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$15.8 Million22.07% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $268M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...